Editorial: Epigenetics in Mammalian Tissues

Rafael Franco^{1

2}, Michael E Symonds³

Affiliations

¹ Department Bioquimica i Biomedicina Molecular, Universitat de Barcelona, Barcelona, Spain.
² CIBERNED, Centro de Investigación en Red, Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.
³ Early Life Research Unit, Division of Child Health, Obstetrics and Gynaecology, and Nottingham Digestive Disease Centre and Biomedical Research Centre, School of Medicine, University of Nottingham, Nottingham, United Kingdom.

Editorial

Rafael Franco et al. Front Genet. 2019.

. 2019 Jul 5:10:635.

doi: 10.3389/fgene.2019.00635. eCollection 2019.

Rafael Franco^{1

2}, Michael E Symonds³

¹ Department Bioquimica i Biomedicina Molecular, Universitat de Barcelona, Barcelona, Spain.
² CIBERNED, Centro de Investigación en Red, Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.
³ Early Life Research Unit, Division of Child Health, Obstetrics and Gynaecology, and Nottingham Digestive Disease Centre and Biomedical Research Centre, School of Medicine, University of Nottingham, Nottingham, United Kingdom.

No abstract available

Keywords: DNA methylation; Turner syndrome (TS); X chromosome; cytocrin; epigenetic abnormalities.

Comment on

1. Cuadrado-Tejedor M., Garcia-Barroso C., Sanzhez-Arias J., Mederos S., Rabal O., Ugarte A., et al. (2015). Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer’s disease. Clin. Epigenetics 7:108. 10.1186/s13148-015-0142-9 - DOI - PMC - PubMed
1. Cuadrado-Tejedor M. L., Ricobaraza A., Torrijo R., Franco R., Garcia-Osta A. (2013). Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer’s disease-like phenotype of a commonly used mouse model. Curr. Pharm. Des. 19 (28), 5076–5084. 10.2174/1381612811319280006 - DOI - PubMed
1. Hall J. G., Gilchrist D. M. (1990). Turner syndrome and its variants. Pediatr. Clin. North Am. 37, 1421–1436. 10.1016/S0031-3955(16)37018-3 - DOI - PubMed
1. Robinson A. (1990). “Demography and prevalence of Turner syndrome,” in Turner syndrome. Eds. Rosenfeld R. G., Grumbach M. M. (New York: Marcell Dekker; ), 93–100.
1. Saenger P., Wikland K. A., Conway G. S., Davenport M., Gravholt C. H., Hintz R., et al. (2001). Recommendations for the diagnosis and management of Turner syndrome. J. Clin. Endocrinol. Metab. 86 (7), 3061–3069. 10.1210/jcem.86.7.7683 - DOI - PubMed